Leukemia & Lymphoma, Volume 64, Issue 9 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 64, Issue 9 (2023)

See all volumes and issues
Vol 65, 2024 Volume 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Commentary

Seeking the right balance in hereditary hematopoietic malignancy diagnosis
Lucy C. Fox
Pages: 1501-1502
Published online: 26 Jul 2023
CitationforSeeking the right balance in hereditary hematopoietic malignancy diagnosis | Full Text | References | PDF (182.6 KB) | EPUB
  • 82 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Articles

Review Article
Precision and strategic targeting of novel mutation-specific vulnerabilities in acute myeloid leukemia: the semi-centennial of 7 + 3
Shyam A. Patel
Pages: 1503-1513
Published online: 16 Jun 2023
AbstractforPrecision and strategic targeting of novel mutation-specific vulnerabilities in acute myeloid leukemia: the semi-centennial of 7 + 3 | Full Text | References | PDF (1.2 MB) | EPUB
  • 1714 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Treatment of older patients with mantle cell lymphoma in the era of novel agents
Alon Rozental, Heather S. L. Jim & Martine Extermann
Pages: 1514-1526
Published online: 26 Jun 2023
AbstractforTreatment of older patients with mantle cell lymphoma in the era of novel agents | Full Text | References | PDF (813.4 KB) | EPUB
  • 464 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Articles

Article
Multi-site pre-therapeutic biopsies demonstrate genetic heterogeneity in patients with newly diagnosed diffuse large B-cell lymphoma
Ditte Stampe Hersby, Lone Schejbel, Marie Fredslund Breinholt, Estrid Høgdall, Peter Nørgaard, Ditte Dencker, Torsten Holm Nielsen, Lars Møller Pedersen & Anne Ortved Gang
Pages: 1527-1535
Published online: 16 Jun 2023
AbstractforMulti-site pre-therapeutic biopsies demonstrate genetic heterogeneity in patients with newly diagnosed diffuse large B-cell lymphoma | Full Text | References | PDF (728.5 KB) | EPUB
  • 166 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Genomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience
Fei Fei, Henning Stehr & James L. Zehnder
Pages: 1536-1544
Published online: 17 Jun 2023
AbstractforGenomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience | Full Text | References | PDF (1,009.9 KB) | EPUB | Supplemental
  • 193 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma
Christian Grommes, Elena Pentsova, Lauren R. Schaff, Craig P. Nolan, Thomas Kaley, Anne S. Reiner, Katherine S. Panageas & Ingo K. Mellinghoff
Pages: 1545-1553
Published online: 15 Jun 2023
AbstractforPreclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma | Full Text | References | PDF (1.5 MB) | EPUB
  • 163 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Incidence of major bleeding in patients with chronic lymphocytic leukemia receiving ibrutinib and therapeutic anticoagulation
Laura M. Roccograndi, Alexandra R. Lovell, Alessandra Ferrajoli, Philip A. Thompson, Jan A. Burger, William G. Wierda, Nitin Jain & Caitlin R. Rausch
Pages: 1554-1561
Published online: 15 Jun 2023
AbstractforIncidence of major bleeding in patients with chronic lymphocytic leukemia receiving ibrutinib and therapeutic anticoagulation | Full Text | References | PDF (623.1 KB) | EPUB
  • 256 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes
Adam Hamidi, Gregory W. Roloff, Reid Shaw, Maria Acevedo, Shaili Smith & Michael W. Drazer
Pages: 1562-1565
Published online: 09 Jun 2023
AbstractforClinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes | Full Text | References | PDF (670.8 KB) | EPUB
  • 828 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature
Vincenzo Guastafierro, Marta Ubezio, Nicla Manes, Chiara Milanesi, Matteo Della Porta & Arturo Bonometti
Pages: 1566-1573
Published online: 03 Jul 2023
AbstractforCSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 271 Views
  • 0 CrossRef citations
  • 0Altmetric

Letters to the Editor

Survival gains in myelodysplastic syndromes following a decade of the modern treatment paradigm
Diego Adrianzen-Herrera, Andrew D. Sparks, Akshee Batra & Neil A. Zakai
Pages: 1574-1578
Published online: 10 Jun 2023
First Page PreviewforSurvival gains in myelodysplastic syndromes following a decade of the modern treatment paradigm | Full Text | References | PDF (562.4 KB) | EPUB | Supplemental
  • 58 Views
  • 0 CrossRef citations
  • 0Altmetric
Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma
Danielle S. Wallace, Chris Rowland, Brian T. Hill, Andrea M. Baran, Carla Casulo, Patrick M. Reagan, Allison Winter, Reem Karmali, Jane N. Winter, Leo I. Gordon, Andrew Bui, Peter Sportelli, Hari P. Miskin, Michael S. Weiss, Jonathan W. Friedberg, Shuo Ma & Paul M. Barr
Pages: 1579-1582
Published online: 21 Jun 2023
First Page PreviewforPhase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma | Full Text | References | PDF (621.7 KB) | EPUB
  • 237 Views
  • 0 CrossRef citations
  • 0Altmetric
Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
Rose Parisi, Emily A. Cowen, Stephanie Gu, Stephen Dusza, Melissa Pulitzer, Mark B. Geyer, Amber C. King & Alina Markova
Pages: 1583-1587
Published online: 12 Jun 2023
First Page PreviewforDermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab | Full Text | References | PDF (585 KB) | EPUB | Supplemental
  • 202 Views
  • 0 CrossRef citations
  • 0Altmetric
Myositis manifesting as respiratory insufficiency with anti-RNA polymerase III antibodies: an unusual presentation of graft-versus-host disease
Louis Wolff, Aurélie Clottu, Anne-Claire Mamez, Camillo Ribi & Francesco Grandoni
Pages: 1588-1591
Published online: 07 Jun 2023
First Page PreviewforMyositis manifesting as respiratory insufficiency with anti-RNA polymerase III antibodies: an unusual presentation of graft-versus-host disease | Full Text | References | PDF (781.4 KB) | EPUB
  • 126 Views
  • 0 CrossRef citations
  • 0Altmetric
Early cytopenias and infections following chimeric antigen receptor T-Cell therapy for hematologic malignancies
Mary McGann, Arash Velayati, Kiera Roubal, Katelynn Granger, James A. Davis, Kelly J. Gaffney, Erin Weeda & Hamza Hashmi
Pages: 1592-1595
Published online: 07 Jun 2023
First Page PreviewforEarly cytopenias and infections following chimeric antigen receptor T-Cell therapy for hematologic malignancies | Full Text | References | PDF (583.7 KB) | EPUB
  • 151 Views
  • 0 CrossRef citations
  • 0Altmetric
Estimating the impact of early bendamustine failure on feasibility of subsequent CAR-T cell therapy in mantle cell lymphoma
Robert Puckrin, Carolyn Owen, Lesley Street, Sarah Perry, Anthea Peters & Douglas Stewart
Pages: 1596-1599
Published online: 20 Jun 2023
First Page PreviewforEstimating the impact of early bendamustine failure on feasibility of subsequent CAR-T cell therapy in mantle cell lymphoma | Full Text | References | PDF (398.1 KB) | EPUB | Supplemental
  • 188 Views
  • 0 CrossRef citations
  • 0Altmetric
Breakthrough COVID-19 is mild in vaccinated patients with hematological malignancy receiving tixagevimab-cilgavimab as pre-exposure prophylaxis
V. G. Hall, C. Lim, N. R. Saunders, E. Klimevski, T. H. O. Nguyen, L. Kedzierski, J. F. Seymour, V. Wadhwa, K. A. Thursky, M. K. Yong, K. Kedzierska, M. A. Slavin & B. W. Teh
Pages: 1600-1604
Published online: 21 Jun 2023
First Page PreviewforBreakthrough COVID-19 is mild in vaccinated patients with hematological malignancy receiving tixagevimab-cilgavimab as pre-exposure prophylaxis | Full Text | References | PDF (569 KB) | EPUB
  • 190 Views
  • 0 CrossRef citations
  • 0Altmetric
Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and FGFR1 rearrangement
Yiru Yan, Shiqiang Qu, Jinqin Liu, Chengwen Li, Xiao Yan, Zefeng Xu, Tiejun Qin, Yujiao Jia, Lijuan Pan, Qingyan Gao, Meng Jiao, Bing Li, Robert Peter Gale & Zhijian Xiao
Pages: 1605-1610
Published online: 24 Jun 2023
First Page PreviewforOlverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and FGFR1 rearrangement | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1096 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles